The Journal of clinical endocrinology and metabolism
Approach to the Patient with Type 2 Diabetes Treated with SGLT-2 Inhibitor: Art of Effective and Safe Prescription.
Aidar R Gosmanov
Published: 202510.1210/clinem/dgaf690
Abstract
Sodium glucose cotransporter-2 (SGLT-2) inhibitors are shown to improve cardiovascular and renal outcomes in people with type 2 diabetes and their use in primary care and subspecialty clinics continues to grow. However, their prescription remains und…
Preview only. Read the full abstract at the source